EGFR and non-small cell lung carcinoma: The EGFR-mutated NSCLC patients presented significantly higher (approx. 2.5-fold) normalised expression level of miR-504 (but not miR-1253 and miR-26a; 4.1) than those with wild-type EGFR (1.7; p < 0.0001).